Lexicon Pharmaceuticals
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381
Phone: (281) 863 3000Website: http://www.lexpharma.com/Careers: www.lexpharma.com/careers
Latest news
- FDA Approves Inpefa (sotagliflozin) for the Treatment of Heart Failure
27 May 2023 - Lexicon Announces FDA Acceptance of New Drug Application for Sotagliflozin to Treat Heart Failure
27 July 2022 - Lexicon Resubmits New Drug Application for Sotagliflozin for the Treatment of Heart Failure
31 May 2022 - Lexicon Submits New Drug Application for Sotagliflozin for the Treatment of Heart Failure in Adults with Type 2 Diabetes
30 December 2021 - Lexicon Pharmaceuticals Provides Regulatory Update on Sotagliflozin in Heart Failure
14 January 2021
Drugs Associated with Lexicon Pharmaceuticals, Inc.
Lexicon Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 2 drugs in the United States. Medications listed here may also be marketed under different names in different countries. Non-US country and region specific information is not available on this page.
| Brand/Generic Name | Reviews | Rating |
|---|---|---|
|
Inpefa
Generic name: sotagliflozin Drug class: SGLT-2 inhibitors |
||
|
Xermelo
Generic name: telotristat Drug class: miscellaneous GI agents |
3 reviews | 8.3 / 10 |
| For ratings, users were asked how effective they found the medicine while considering positive/adverse effects and ease of use (1 = not effective, 10 = most effective). | ||